Internal Medicine, Infectious Disease · Augusta, GA
NPI
1740357425
Since 2006
Specialty
Internal Medicine, Infectious Disease
Code 207RI0200X
Group practices
1
Medicare group memberships
Hospitals
2
Hospital affiliations
2050 Walton Way Ste 101
Augusta, GA, 30904
Phone (706) 434-1590
Groups this clinician bills Medicare through
Medicare paid, 2024
$28K
372 services
Medicare patients, 2024
136
Average age 69
Drug cost, 2024
$2.7M
1,883 prescriptions
Company payments, 2025
$536
From 11 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Kepler A Davis was code 99233 (hospital e&m - subsequent), 178 times for 82 patients. In total Kepler A Davis billed 372 services in 18 codes, and Medicare paid $28K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2019-09-10.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99233 Hospital E&M - Subsequent | Facility | 178 | 82 | $84.37 | $15K |
| 99232 Hospital E&M - Subsequent | Facility | 81 | 53 | $55.93 | $4,530 |
| 99223 Hospital E&M - Initial | Facility | 52 | 51 | $122.15 | $6,352 |
| G2011 Alcohol and/or substance (other than tobacco) misuse structured assessment (e.g., audit, dast), and brief intervention, 5-14 minutes | Office | 21 | 21 | $12.08 | $254 |
By year: 2022 $39K for 575 services; 2023 $25K for 296 services; 2024 $28K for 372 services.
Medicare prescription drug claims, 2024
In 2024, the drug Kepler A Davis prescribed most often to Medicare patients was Biktarvy (Bictegrav/Emtricit/Tenofov Ala), with 234 prescriptions and refills. In total Kepler A Davis wrote 1,883 Medicare prescriptions that cost $2.7M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Biktarvy Bictegrav/Emtricit/Tenofov Ala | 234 | 238 | 26 | $850K |
| Dovato Dolutegravir Sodium/Lamivudine | 111 | 119 | 12 | $327K |
| Descovy Emtricitabine/Tenofov Alafenam | 105 | 105 | 12 | $229K |
| Triumeq Abacavir/Dolutegravir/Lamivudi | 97 | 103 | Under 11 | $358K |
| Ertapenem Ertapenem Sodium | 96 | 96 | 17 | $48K |
| Doxycycline Hyclate Generic | 95 | 181 | 43 | $2,693 |
| Daptomycin Generic | 86 | 86 | 27 | $136K |
| Ceftriaxone Ceftriaxone Sodium | 75 | 75 | 19 | $6,940 |
| Tivicay Dolutegravir Sodium | 64 | 64 | Under 11 | $146K |
| Vancomycin Hcl Generic | 55 | 55 | 12 | $8,954 |
| Cephalexin Generic | 52 | 110 | 22 | $1,822 |
| Ciprofloxacin Hcl Generic | 49 | 74 | 23 | $877 |
| Sulfamethoxazole-Trimethoprim Sulfamethoxazole/Trimethoprim | 45 | 74 | 20 | $626 |
| Cefepime Hcl Generic | 43 | 43 | 11 | $7,373 |
| Cefazolin Sodium Generic | 42 | 42 | Under 11 | $1,892 |
Brand drugs: 882 claims; generic drugs: 1,001 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Kepler A Davis $536 ($536 in general payments such as food, travel and fees) from 11 companies. The largest payer was ViiV Healthcare Company with $202.
| Company | Payments | Amount |
|---|---|---|
| ViiV Healthcare Company GSK | 9 | $202 |
| Merck Sharp & Dohme LLC MRK | 6 | $112 |
| GlaxoSmithKline, LLC. GSK | 2 | $36.92 |
| Ferring Pharmaceuticals Inc. | 2 | $35.26 |
| EMD Serono, Inc. MRK.DE | 1 | $31.13 |
| Abbvie Inc. ABBV | 1 | $25.55 |
| Gilead Sciences, Inc. GILD | 1 | $20.41 |
| La Jolla Pharmaceutical Company | 1 | $20.05 |
| Astellas Pharma US Inc 4503.T | 1 | $18.17 |
| Aimmune Therapeutics, Inc. | 1 | $17.65 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.